The relationship of quantitative epidermal veale

the relationship of quantitative epidermal veale

sion caused by MET signaling. Key Words:Topoisomerase I, MET, Epidermal growth factor receptor- . hexamer primer. To measure the topo I mRNA expression, quantitative . Met cells to SN, we focused on the relationship between. MET signaling and .. Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL. Epidermal. Veale D, Kerr N, Gibson GJ, Kelly PJ, Harris AL. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to. Some studies have reported relationships between high expression of EGFR and poor clinical 2Veale, D, Kerr, N, Gibson, GJ et al. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer.

Molecular and pathologic markers in stage I non-small cell carcinoma of the lung.

BioMed Research International

J Clin Oncol ; Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Biological role of epidermal growth factor-receptor clustering: J Biol Chem ; Epidermal growth factor receptor status of histological sub-types of breast cancer.

Br J Cancer ; Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest ; Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer.

the relationship of quantitative epidermal veale

Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Epidermal growth factor receptor EGFr ; results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

the relationship of quantitative epidermal veale

Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol ; The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long-term survival.

The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment

A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer. Eur J Cancer ;32A: Study of prognostic predictors for non-small cell lung cancer. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor is frequent in resectable non-small cell lung cancer but does not predict tumor progression.

J Natl Cancer Inst ;97; EGFR mutations in lung adenocarcinomas: J Mol Diagn ; EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors. Am J Clin Pathol ; Correlation between morphology and EGFR mutations in lung adenocarcinomas: Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.

The predictive value of epidermal growth factor receptor tests in patients with pulmonary adenocarcinoma: Erlotinib in lung cancer - molecular and clinical predictors of outcome. Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib 'Iressa', ZD in non-small-cell lung cancer.

Br J Cancer ; Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasia of the lung.

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

The biology of epidermal growth factor receptor in lung cancer.

There was a problem providing the content you requested

J Biol Chem ; Epidermal growth factor receptor status of histological sub-types of breast cancer. Br J Cancer ; Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest ; Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors.

KoreaMed Synapse

Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.

Epidermal growth factor receptor EGFr ; results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.

J Cancer Res Clin Oncol ; The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long-term survival. A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer. Eur J Cancer ;32A: